Remibrutinib Open Label Roll-over Post-trial Access Protocol
Remibrutinib Open Label Roll-over Post-trial Access Protocol
Recruiting · NCT07456891 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Remibrutinib Open Label Roll-over Post-trial Access Protocol | Indication of the Parent Protocol | Recruiting | Phase 3 | 2026-09-25 | NCT07456891 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||